Why PMCF is Mandatory Under EU MDR 2017/745

Q: What are the typical PMCF activities?

Common PMCF activities include high-quality physician/patient surveys (PROMs), prospective observational studies, and extracting Real-World Evidence (RWE) from national or European device registries.

Under the legacy Medical Device Directive (MDD), Post-Market Surveillance (PMS) was largely a reactive process—manufacturers waited for complaints or adverse events to roll in before acting. The EU MDR 2017/745 shattered this paradigm.

Today, regulatory affairs teams face a fundamental question: why pmcf eu mdr compliance is treated with such aggressive scrutiny by Notified Bodies? The answer lies in the shift from passive observation to proactive clinical data collection.

"Under EU MDR, absence of evidence is not evidence of safety. If you are not proactively collecting clinical data on your device in the real world, your Technical Documentation is considered fundamentally non-compliant."

1. The Legal Mandate: PMCF Annex XIV Part B

To understand why pmcf mandatory eu mdr enforcement is so strict, we must look at the law. PMCF Annex XIV Part B explicitly defines PMCF as a continuous, proactive process that updates the Clinical Evaluation Report (CER).

The goal is to systematically gather clinical data to:

→ Confirm the safety and performance of the device throughout its expected lifetime.
→ Identify previously unknown side-effects or monitor known side-effects.
→ Identify and analyze emergent risks on the basis of factual evidence.
→ Ensure the continued acceptability of the benefit-risk ratio (feeding directly back into ISO 14971 Risk Management).

2. PMCF Obligations by Device Class

While the regulation applies to all medical devices, the pmcf obligations medical device manufacturers face scale directly with the risk class. What satisfies a Notified Body for a Class I software tool will result in a major non-conformity for a Class III implant.

Device Class	PMCF Obligation & Expectation	Typical Evidence Strategy
Class I & IIa	PMCF is required, but it is often possible to justify not conducting a specific new clinical study, provided that PMS and literature data are overwhelmingly robust.	PMCF Surveys (Physician/Patient PROMs), robust literature reviews, and structured proactive PMS data.
Class IIb	A proactive PMCF study is generally expected by Notified Bodies. If you choose not to conduct one, the justification (e.g., Well-Established Technology / WET) must be flawless and heavily documented.	High-level structured Surveys, retrospective EHR data extraction, or lightweight prospective observational studies.
Class III & Implantables	Strictly Mandatory. A rigorous, proactive PMCF clinical investigation is non-negotiable. Absence of a PMCF study will lead to immediate certification suspension.	Prospective Observational Studies, integration with European Registries (NJR, EPRD), and complex longitudinal PROMs.

3. Explore the Types of PMCF Activities

There is no "one size fits all" PMCF strategy. The fact that pmcf eu mdr crucial compliance depends on choosing the right methodology is why Eclevar MedTech offers specialized pathways to generate clinical data cost-effectively.

Choose the methodology that aligns with your device class and budget:

PMCF Surveys

The most cost-effective method for Class I to IIb devices. We design ISO 14155-compliant physician and patient (PROMs) surveys that carry actual regulatory weight, not just marketing feedback.

Discover PMCF Surveys

Observational Studies

For high-risk devices requiring longitudinal data. We execute lightweight, prospective PMCF studies using our proprietary EDC system to capture real-world safety and performance without RCT overhead.

Explore Observational PMCF

Registry Strategy (RWE)

Why run your own trial if the data already exists? Learn how to extract Real-World Evidence (RWE) from European registries (like NJR, EPRD, Swespine) to satisfy MDR requirements instantly.

Read the Registry Guide

The PMCF Plan

The document that dictates your entire strategy. Our medical writers and former Notified Body reviewers draft bulletproof PMCF Plans that secure immediate approval during your technical file audit.

Master the PMCF Plan

Free Resource (2026 Edition)

Download the PMCF Plan Template

Don't start from a blank page. Download the exact PMCF Plan structure recommended by former Notified Body reviewers to guarantee Annex XIV compliance.

Download Template

4. Frequently Asked Questions

Why is PMCF mandatory under EU MDR?

Under EU MDR Annex XIV Part B, passive post-market surveillance is no longer sufficient. PMCF is mandatory to continuously and proactively confirm the safety and clinical performance of the device throughout its entire expected lifetime, and to ensure the benefit-risk ratio remains acceptable.

Can we justify not conducting a PMCF study?

For low-risk devices (Class I, IIa), it may be possible to justify not conducting a specific PMCF study if existing clinical data is overwhelmingly robust. However, this justification must be heavily documented in the PMCF Plan. For Class IIb and Class III devices, PMCF studies are generally strictly required by Notified Bodies.

What are the typical PMCF activities?

Common PMCF activities include high-quality physician and patient surveys (PROMs), prospective observational studies, and extracting Real-World Evidence (RWE) from national or European medical device registries.

Why PMCF is So Crucial Under EU MDR | Post-Market Requirements